Overview A Drug Interaction Study of Danicopan Status: Completed Trial end date: 2020-04-17 Target enrollment: Participant gender: Summary This was a 3-part study (Part 1, Part 2, Part 3) with each part being an open-label, fixed sequence, 2-period study in healthy adult participants. Phase: Phase 1 Details Lead Sponsor: Alexion PharmaceuticalsCollaborators: Achillion, a wholly owned subsidiary of AlexionCelerionTreatments: BupropionEstradiolEthinyl EstradiolNorethindroneNorethindrone AcetateNorethindrone acetate, ethinyl estradiol, ferrous fumarate drug combinationNorinylWarfarin